Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
Abstract
A blood storage system. The system has a collection bag for red blood cells; an oxygen/carbon dioxide depletion device; a storage bag for red blood cells; and tubing connecting the collection bag to the depletion device and the depletion device to the storage bag. The depletion device includes a receptacle of a solid material having an inlet and an outlet adapted to receiving and expelling a flushing gas; a plurality of hollow fibers or gas-permeable films extending within the receptacle from an entrance to an exit thereof. The hollow fibers or gas-permeable films are adapted to receiving and conveying red blood cells.
Claims
exact text as granted — not AI-modified1 .- 20 . (canceled)
21 . A red blood cell composition comprising:
re-oxygenated stored red blood cells wherein said red blood cells were depleted of oxygen and carbon dioxide and stored under oxygen and carbon dioxide depleted conditions at a temperature of 1° C. to 6° C. for a period of time.
22 . The red blood cell composition of claim 21 , wherein said re-oxygenated stored red blood cells were stored for 1 week and have a 2-3,biphosphoglycerate (DPG) level of at least 15 μmol/g Hb, were stored for 2 weeks and have a DPG level of at least 15 μmol/g Hb, were stored for 2.5 weeks and have a DPG level of at least 1 μmol/g Hb, or were stored for 3 weeks and have a DPG level of at least 1 μmol/g Hb.
23 . The red blood cell composition of claim 21 , wherein said re-oxygenated stored red blood cells have been depleted of leukocytes.
24 . The red blood cell composition of claim 21 , wherein said re-oxygenated stored red blood cells have been depleted of platelets.
25 . A method for optimizing stored red blood cells comprising:
depleting both oxygen and carbon dioxide from red blood cells to produce oxygen and carbon dioxide depleted red blood cells; storing said oxygen and carbon dioxide depleted red blood cells in an anaerobic storage bag; and re-oxygenating said stored oxygen and carbon dioxide depleted red blood cells prior to transfusion.
26 . A method in claim 25 , wherein said red blood cells comprise an additive solution provided prior to said depleting of oxygen and carbon dioxide.
27 . A method in claim 26 , wherein said additive solution comprises OFAS3, AS1, AS3, AS5, SAGM or MAPS.
28 . A method in claim 25 , further comprising reducing leukocytes from said red blood cells.
29 . A method in claim 25 , further comprising reducing platelets from said red blood cells.
30 . A method of claim 25 , wherein said red blood cells are leukocyte reduced.
31 . A method of claim 25 , wherein said red blood cells are platelet reduced.
32 . A method in claim 25 , wherein said oxygen and carbon dioxide depleted red blood cells are maintained in an oxygen and carbon dioxide depleted environment during said storing.
33 . The method in claim 25 , wherein said depleting of oxygen and carbon dioxide occurs prior to cooling said red blood cells to a storage temperature of 1° C. to 6° C.
34 . The method in claim 33 , wherein said depleting occurs at room temperature.
35 . A method in claim 25 , wherein said re-oxygenating occurs immediately prior to transfusion.
36 . A method in claim 25 , wherein said re-oxygenating is performed using a gas flush device and flushing with oxygen or air.
37 . A method in claim 36 , wherein said flushing is with air.
38 . A method in claim 36 , wherein said flushing is with pure oxygen.
39 . A method for maintaining 2-3,biphosphoglycerate (DPG) levels in red blood cells for transfusion comprising:
mixing red blood cells with an additive solution; reducing leukocytes and platelets from said red blood cells; passing said red blood cells through an oxygen and carbon dioxide depletion device to prepare oxygen and carbon dioxide depleted red blood cells; storing said oxygen and carbon dioxide depleted red blood cells in an anaerobic storage bag; and re-oxygenating said stored oxygen and carbon dioxide depleted red blood cells prior to transfusion.
40 . A method in 39 , wherein said additive solution comprises OFAS3, AS1, AS3, AS5, SAGM or MAPS.Join the waitlist — get patent alerts
Track US2015284682A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.